Repligen Corporation’s filing revealed that its Chief Financial Officer Snodgres Jon unloaded Company’s shares for reported $1.13 million on Feb 16. In the deal valued at $200.00 per share,5,647 shares were sold. As a result of this transaction, Snodgres Jon now holds 29,325 shares worth roughly $ 5.09 million.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Then, Hunt Anthony sold 25,000 shares, generating $5,000,000 in total proceeds. Upon selling the shares at $200.00, the Chief Executive Officer now owns 178,265 shares.
Before that, DAWES KAREN A sold 775 shares. Repligen Corporation shares valued at $176,057 were divested by the Director at a price of $227.17 per share. As a result of the transaction, DAWES KAREN A now holds 76,401 shares, worth roughly $13.25 million.
Deutsche Bank initiated its Repligen Corporation [RGEN] rating to a Hold in a research note published On Friday, December 14, 2022; the price target was $180. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in early December with a ‘”a Sector perform”‘ rating. UBS began covering RGEN with “Buy” recommendation on July 20, 2022. Exane BNP Paribas started covering the stock on October 14, 2021. It rated RGEN as “an Outperform”.
Price Performance Review of RGEN
On Friday, Repligen Corporation [NASDAQ:RGEN] saw its stock fall -5.54% to $173.44. Over the last five days, the stock has lost -12.45%. Repligen Corporation shares have risen nearly 2.44% since the year began. Nevertheless, the stocks have fallen -0.78% over the past one year. While a 52-week high of $262.26 was reached on 02/16/23, a 52-week low of $137.21 was recorded on 01/06/23. SMA at 50 days reached $178.84, while 200 days put it at $186.41. A total of 0.87 million shares were traded, compared to the trading of 1.18 million shares in the previous session.
Levels Of Support And Resistance For RGEN Stock
The 24-hour chart illustrates a support level at 169.04, which if violated will result in even more drops to 164.63. On the upside, there is a resistance level at 181.29. A further resistance level may holdings at 189.13. The Relative Strength Index (RSI) on the 14-day chart is 43.35, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -10.95, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 74.55%. Stochastics %K at 31.50% indicates the stock is a holding.
How much short interest is there in Repligen Corporation?
A steep rise in short interest was recorded in Repligen Corporation stocks on Jan 12, 2023, growing by 0.48 million shares to a total of 4.07 million shares. Yahoo Finance data shows the prior-month short interest on Dec 14, 2022 was 3.59 million shares. There was a rise of 11.79%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 7.36% of the overall stock float, the days-to-cover ratio (short ratio) rose to 8.38.
Repligen Corporation [RGEN] – Who Are The Largest Shareholders?
In filings from The Vanguard Group, Inc., it is revealed that the company now owns 5,131,246 shares, or roughly 9.24% of the outstanding RGEN shares. In other words, the investor’s shares have risen by 75,212 from its previous 13-F filing of 5056034.0. Additionally, T. Rowe Price Associates, Inc. increased 38.56% of its stake after which the total value it holdings stand at $939,592,742, while BlackRock Fund Advisors added 5.89% of its stake to hold $894.89 million in the firm. Over the last quarter, Sands Capital Management LLC purchased 142,480 shares of Repligen Corporation, while WCM Investment Management LLC bought 82,356 shares. At present, SSgA Funds Management, Inc. is holding 1,599,994 shares valued at $296.48 million. Brown Capital Management LLC owned 1,452,335 shares of the company at the time of its most recent 13F filing, worth $269.12 million.
The most recent change occurred on November 10, 2020 when KeyBanc Capital Markets began covering the stock and recommended ‘”an Overweight”‘ rating along with a $241 price target.